Get the Stockscreener App
4.32
0.69%
-0.03
Koru Medical Systems Inc stock is traded at $4.32, with a volume of 135.61K.
It is down -0.69% in the last 24 hours and up +4.35% over the past month.
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
See More
Previous Close:
$4.35
Open:
$4.3
24h Volume:
135.61K
Relative Volume:
1.48
Market Cap:
$199.74M
Revenue:
$33.65M
Net Income/Loss:
$-6.07M
P/E Ratio:
-36.00
EPS:
-0.12
Net Cash Flow:
$-1.66M
1W Performance:
+10.77%
1M Performance:
+4.35%
6M Performance:
+43.52%
1Y Performance:
+40.26%
1-Day Range:
$4.19
$4.40
1-Week Range:
$3.71
$4.49
52-Week Range:
$1.86
$5.05
Koru Medical Systems Inc Stock (KRMD) Company Profile
Name
Koru Medical Systems Inc
Sector
Industry
Phone
845-469-2042
Address
100 CORPORATE DRIVE, MAHWAH, NY
Compare KRMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KRMD
Koru Medical Systems Inc
|
4.32 | 201.50M | 33.65M | -6.07M | -1.66M | -0.12 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Koru Medical Systems Inc Stock (KRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Sep-07-23 | Initiated | B. Riley Securities | Buy |
| Sep-07-23 | Initiated | Lake Street | Buy |
| Nov-10-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-10-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-26-21 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-26-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-10-20 | Initiated | H.C. Wainwright | Buy |
| Jul-16-20 | Initiated | Canaccord Genuity | Buy |
| Jun-24-20 | Initiated | Piper Sandler | Overweight |
View All
Koru Medical Systems Inc Stock (KRMD) Latest News
KORU Medical Systems Inc. stock momentum explainedWeekly Risk Report & Advanced Swing Trade Entry Plans - newser.com
Institutional scanner results for KORU Medical Systems Inc.Portfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Real time scanner hits for KORU Medical Systems Inc. explainedJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2025 Earnings Call Transcript - Insider Monkey
Full technical analysis of KORU Medical Systems Inc. stockJuly 2025 Update & Safe Capital Allocation Plans - newser.com
Repro-Med Systems’ Earnings Call Highlights Growth and Challenges - TipRanks
KORU Medical Systems Inc. stock trend outlook and recovery pathWeekly Investment Summary & Stock Market Timing Techniques - newser.com
Is KORU Medical Systems Inc. stock cheap compared to fundamentalsJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - newser.com
KORU Medical (NASDAQ: KRMD) sets Piper Sandler Dec 2, 9:30 ET; Craig-Hallum, Canaccord - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
KORU Medical Systems Q3 2025 revenue up 27% to USD 10.4M - Medical Buyer
KRMD Shares Rise After Strong Q3 Revenue Growth And Raised 2025 Guidance - Nasdaq
Koru Medical Systems stock maintains Buy rating at Canaccord on strong growth - Investing.com
KORU Medical Systems Inc (KRMD) Q3 2025 Earnings Call Highlights - GuruFocus
KORU Medical Systems Inc (KRMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
What valuation multiples suggest for KORU Medical Systems Inc. stockJuly 2025 EndofMonth & Accurate Entry and Exit Point Alerts - newser.com
KORU Medical Systems Q3 2025 Earnings Call Transcript - MarketBeat
KORU Medical Systems Reports Strong Q3 Growth - TipRanks
KORU Medical Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates - sharewise.com
KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance - BioSpace
Earnings call transcript: KORU Medical Q3 2025 sees revenue growth, stock rises - Investing.com Nigeria
KORU Medical Systems Lifts Outlook After Global Sales Growth - Finimize
KORU Medical (KRMD) Exceeds Q3 Revenue Expectations with Strategic Growth - GuruFocus
KRMD's Financial Outlook: Revenue Consensus and Margin Guidance - GuruFocus
Infusion pump maker KORU Medical Q3 revenue jumps, raises 2025 rev guidance - MarketScreener
Alvotech (NASDAQ: ALVO) receives CHMP positive opinion for AVT03, Prolia/Xgeva biosimilar - Stock Titan
Is KORU Medical Systems Inc a good long term investmentInsider Buying Signals & Stay One Step Ahead of Risk Events - earlytimes.in
KORU Medical Systems Inc (KRMD) Q3 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Can a trend reversal in KORU Medical Systems Inc. lead to recoveryJuly 2025 Market Mood & AI Driven Stock Price Forecasts - newser.com
Key metrics from KORU Medical Systems Inc.’s quarterly dataJuly 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com
How KORU Medical Systems Inc. stock reacts to bond yieldsJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Koru Medical Systems Inc Stock (KRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):